FRANCIS E. ODONNELL JR - 13 Dec 2022 Form 3 Insider Report for Inhibitor Therapeutics, Inc. (INTI)

Role: Chief Executive Officer, Executive Chairman of the Board, Director, 10%+ Owner
Signature: /s/ Francis O'Donnell
Issuer symbol: INTI
Transactions as of: 13 Dec 2022
Net transactions value: $0
Form type: 3
Filing time: 22 Dec 2022, 20:33:18 UTC
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	INTI	Common Stock						85,627,069	13 Dec 2022	See Footnotes	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares represent 6,000,000 shares of common stock held by Hopkins Capital Group II, LLC ("HCG II LLC") and 79,627,069 shares of common stock held by Hedgepath, LLC ("HP LLC").
F2	Francis E. O'Donnell Irrevocable Trust #1 owns 28.12% of HCG II LLC and Francis E. O'Donnell Descendants Trust owns 3.13% of HCG II LLC. Kathleen M . O'Donnell, Dr. O'Donnell's sister, is the trustee of Francis E. O'Donnell Irrevocable Trust #1 and Francis E. O'Donnell Descendants Trust. Dr. O'Donnell does not have voting and dispositive control over any of these shares and disclaims any beneficial ownership of the reported shares held by HCG II LLC other than to the extent of any pecuniary interest he may have therein, directly or indirectly.
F3	The Francis E. O'Donnell Jr. Irrevocable Trust #7 owns 26.5% of HP LLC. Kathleen M. O'Donnell, Dr. O'Donnell's sister, is the trustee of HP LLC. Dr. O'Donnell does not have voting and dispositive control over any of these shares and disclaims any beneficial ownership of the reported shares held by HP LLC other than to the extent of any pecuniary interest he may have therein, directly or indirectly.

Remarks:

Chief Executive Officer, Executive Chairman of the Board